Cantargia Announces AACR 2026 Presentation of Study Design and Supportive Pre-Clinical Data for Investigator-Initiated Nadunolimab Study in MSS CRC

Cantargia AB (Publ) (Nasdaq Stockholm:CANTA) today reported that the rationale and study design of the phase 1b/2 clinical trial investigating nadunolimab in combination with immune-checkpoint ...
Healio

Different study designs show varying COVID-19 vaccine effectiveness in patients with CKD

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A test-negative observational study design may be best ...
News-Medical.Net

Obesity research trends and lab challenges

Explore how evolving obesity research is shaping trial design, with a focus on precision, reproducibility, and clinical ...
Health Affairs

The Taxpayer-Funded GRAIL Galleri-Medicare Study: A Flawed Design

The Galleri-Medicare study called REACH (Real-world Evidence to Advance Multi-Cancer Early Detection Health Equity) is a non-randomized, observational study of 50,000 Medicare beneficiaries. The ...